BioAge Labs, Inc. (NASDAQ:BIOA) Financings

BioAge Labs, Inc.

Financings

RaiseDate
Public offering of shares of common stock
Made bigger: about US$115M · US$19.5 a share · Goldman Sachs & Co. LLC +2
Dealers: Goldman Sachs & Co. LLC (co-lead), Piper Sandler (co-lead), Citigroup (co-lead)
Use of proceeds: R&D, clinical and manufacturing of product candidates incl. BGE-102, NLRP3 and APJ programs; working capital, capex, debt reduction, general corporate purposes
Jan 22, 2026

Read by 6ix AI from the company's releases